alexa Primary progressive aphasia | India| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Primary Progressive Aphasia

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Primary progressive aphasia

    Disease pathophysiology:

    Primary progressive aphasia (PPA) is a clinical syndrome defined by the insidious onset and progressive dissolution of language skills. Although additional cognitive symptoms may emerge later in the course of illness, deficits must be grossly confined to the area of language for at least 2 years to fulfill the criteria for a diagnosis of PPA.

  • Primary progressive aphasia

    Disease statistics:

    In about 70% of individuals with the logopenic variant of PPA, inspection of the brain at autopsy reveals the accumulation of amyloid plaques and tau neurofibrillary tangles. These are the microscopic characteristics of Alzheimer’s disease. These individuals with the logopenic variant of PPA thus can be thought to have an unusual variant of Alzheimer’s disease that begins by affecting the language regions of the brain.

  • Primary progressive aphasia

    Disease treatment:

    Evaluation by speech therapist to improve and explore alternative communicative strategies may be useful. Non therapeutic measures like learning sign language and use of voice synthesizers or laminated cards to communicate may be beneficial. As many patients continue to be independent and active, it is important to explain the disease and the prognosis to the patient.

  • Primary progressive aphasia

    Major research on disease:

    Differentiating the clinicopathological types is important to evaluate new therapeutic strategies in FTLD or to use disease modifying treatments in AD. As PPA is a focal neurodegeneration with a prolonged longitudinal course it offers an excellent opportunity to develop disease modifying therapies to slow or arrest progression.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings